Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploratory study of selected stakeholder insights into continuous glucose monitoring in T2D with risk-sharing agreements.

The American journal of managed care·2026
Same author

Robust PD-1 blockade compromises clonal affinity of stem-like CD8<sup>+</sup> T cells.

Immunology and cell biology·2025
Same author

Transcriptional regulator SATB1 limits CD8<sup>+</sup> T cell population expansion and effector differentiation in chronic infection and cancer.

Nature immunology·2025
Same author

Stakeholder insights on cost, quality, and incorporating patient voice in managed care decisions on neovascular (wet) age-related macular degeneration: Findings from the AMCP Market Insights program.

Journal of managed care & specialty pharmacy·2024
Same author

Benefits of dapagliflozin in chronic kidney disease for US commercial payers: A cost-offset analysis.

Journal of managed care & specialty pharmacy·2024
Same author

Pregnancy snapshot: a retrospective, observational case-control study to evaluate the potential effects of maternal diabetes treatment during pregnancy on macrosomia.

Current medical research and opinion·2016
Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023
Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023
Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023
Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023
Same journal

Renewing the dream.

The Journal of family practice·2023
Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023
See all related articles

Related Experiment Video

Updated: May 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Managing hypoglycemia in primary care.

Penny Tenzer-Iglesias1, Michael H Shannon

  • 1Department of Family Medicine and Community Health, University of Miami Hospital, Miami, FL, USA.

The Journal of Family Practice
|October 30, 2012
PubMed
Summary
This summary is machine-generated.

This study compares hypoglycemia risks across glucose-lowering agents, identifying patient factors and physician strategies to mitigate risks. Education is key for managing hypoglycemia in diabetes care.

Related Experiment Videos

Last Updated: May 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

  • Endocrinology
  • Pharmacology
  • Diabetes Management

Background:

  • Hypoglycemia is a significant adverse event in diabetes management.
  • Glucose-lowering agents vary in their propensity to cause hypoglycemia.
  • Identifying at-risk patients and implementing preventive strategies is crucial.

Purpose of the Study:

  • To compare the hypoglycemia risk associated with different glucose-lowering agents.
  • To identify patient-specific risk factors and behaviors contributing to hypoglycemia.
  • To outline physician techniques for risk assessment and patient education on hypoglycemia prevention.

Main Methods:

  • Systematic review of clinical trials and observational studies.
  • Analysis of adverse event reporting databases.
  • Development of risk stratification tools.
  • Evaluation of educational intervention effectiveness.

Main Results:

  • Specific glucose-lowering agents demonstrate higher hypoglycemia rates.
  • Patient factors (e.g., age, renal function, comorbidities) significantly influence risk.
  • Behavioral factors (e.g., medication adherence, diet) play a critical role.
  • Physician-led risk assessment and targeted education improve hypoglycemia awareness and outcomes.

Conclusions:

  • Risk stratification and personalized management are essential for minimizing hypoglycemia.
  • Effective patient education empowers individuals to manage hypoglycemia risks.
  • Continuous monitoring and adaptation of treatment plans are necessary for safe diabetes care.